Influenza vaccines Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines <5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants National Immunisation Program Schedule vaccines Mpox (monkeypox)vaccine AusVaxSafety commenced routine safety monitoring of 2022 seasonal influenza vaccines used in Australia across all ages in April 2022. The vaccines currently in use are Vaxigrip Tetra®, Fluarix Tetra®, Afluria® Quad (5 years and older), FluQuadri®, Flucelvax® Quad (2 years and older), Influvac® Tetra, Fluad® Quad (65 years and over) and Fluzone® High-Dose Quadrivalent (60 years and over). Surveillance data are provided by AusVaxSafety surveillance tools and are based on vaccine safety surveys sent in the days following influenza vaccination. Influenza vaccine safety data for 2023 will be published once influenza vaccines become available and the surveillance program commences. Latest influenza vaccine safety data Click on the tiles below to view 2022 AusVaxSafety influenza vaccine safety data for specific age and population groups. There are currently insufficient data to conduct meaningful analysis for the participants aged <5 years, Aboriginal and Torres Strait Islander participants and pregnant participants groups. Influenza vaccine safety data - <5 years View the latest safety data here Influenza vaccine safety data - 5 years and older (standard vaccines) View the latest safety data here Influenza vaccine safety data - 60 years and older (adjuvanted or high dose vaccine) View the latest safety data here Influenza vaccine safety data - Pregnant participants View the latest safety data here Influenza vaccine safety data - Aboriginal and Torres Strait Islander View the latest safety data here Vaccine safety data Main navigation COVID-19 vaccines Influenza vaccines <5 years 5 years and older (standard vaccines) 60 years and older (adjuvanted or high dose vaccine) Pregnant participants Aboriginal and Torres Strait Islander participants National Immunisation Program Schedule vaccines Mpox (monkeypox)vaccine News & events All news & events 26 February 2023 | News What is a bivalent COVID-19 vaccine and how do the short-term side effects compare to the original COVID-19 booster vaccines? 10 February 2023 | News Update to AusVaxSafety COVID-19 vaccine safety data reporting 31 January 2023 | News Short-term adverse event profile of COVID-19 mRNA vaccines in Aussie kids: reassuring data from AusVaxSafety 22 December 2022 | News How common are severe side effects from COVID vaccines? And how are they detected?